Synthroid

Pharma

AbbVie locks in US pricing deal as it pledges $100B investment

Though not the first pharma to strike a U.S. pricing deal, AbbVie’s new accord is notable for the sheer size of the investment pledge that comes with.

Fraiser Kansteiner Jan 13, 2026 9:15am

New manufacturing issues lead AbbVie to 2nd Synthroid recall

Jan 14, 2013 3:14pm